Development of secondary anaplastic oligoastrocytoma after matched unrelated bone marrow transplantation in a child with acute myeloid leukemia

Acta Haematologica

Volumn 109, Issue 4, 2003, Pages 196-198

  Panigrahi, Soumya ^a   Das, Mayukh ^a   Stagler, Dalia ^b   Konstantini, Shlomi ^c   Gmori, Moshe ^a   Slavin, Shimon ^a   Nagler, Arnon ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b Elias Sorasky Medical Center   (Israel)

^c KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Acute myeloid leukemia; Bone marrow transplantation, allogeneic; CNS insult; Oligoastrocytoma

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; CYTOTOXIC AGENT; ETOPOSIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BRAIN RADIATION; BRAIN TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CASE REPORT; CENTRAL NERVOUS SYSTEM; CHILDHOOD LEUKEMIA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; GLIOBLASTOMA; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MULTIMODALITY CANCER THERAPY; NEUROLOGIC DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SEIZURE; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; ASTROCYTOMA; BONE MARROW TRANSPLANTATION; BRAIN NEOPLASMS; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, SPINAL; LEUKEMIA, MONOCYTIC, ACUTE; MALE; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PARIETAL LOBE; REMISSION INDUCTION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 0038649179     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070970     Document Type: Article

References (15)

1. Kolb HJ, Poetscher C: Late effects after allogeneic bone marrow transplantation. Curr Opin Hematol 1997;4:401-407.
2. Atree SV, Crilley PA, Conroy JF, Micaily B, Brodsky JT: Cancer of the esophagus following allogeneic bone marrow transplantation for acute leukemia. Am J Clin Oncol 1995;18:343-347.
3. Matsuo K, Kondoh E, Mitome M, Takeuchi M, Matsue K: Development of cerebellar astrocytoma in a patient with acute myeloid leukemia years after his second bone marrow transplant. Rinsho Ketsueki 1999;40:427-429.
4. Meignin V, Gluckman E, Gambarelli D, Devergie A, Ramee MP, Janin A, Socie G: Meningioma in long term survivors after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998;22:723-724.
5. Cohen A, Rovelli A, van Lint MT, Merlo F, Gaiero A, Mulas R, Balduzzi A, Corti P, Uderzo C, Bacigalupo A: Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood. Bone Marrow Transplant 2001;28:1125-1128.
6. Bhatia S, Louie AD, Bhatia R, O'Donnell MR, Fung H, Kashyap A, Krishnan A, Molina A, Nademanee A, Niland JC, Parker PA, Snyder DS, Spielberger R, Stein A, Forman SJ: Solid cancers after bone marrow transplantation. J Clin Oncol 2001;19:464-471.
7. Deeg HJ, Witherspoon RP: Risk factors for the development of secondary malignancies after bone marrow transplantation. Hematol Oncol Clin North Am 1993;7:417-429.
8. Kolb HJ, Socie G, Duell T, Van Lint MT, Tichelli A, Apperley JF, Nekolla E, Ljungman P, Jacobsen N, Weel MV, Wick R, Weiss M, Prentice HG: Malignant neoplasms in long term survivors of bone marrow transplantation. Ann Intern Med 1999;131:738-744.
9. Curtis RE, Rowlings PA, Deeg JH, Shriner DA, Socie G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF Jr, Boice JD: Solid cancer after bone marrow transplantation. N Engl J Med 1997;336:897-904.
10. Maintz D, Fiedler K, Koopmann J, Rollbroker B, Nechev S, Lenartz D, Stangl AP, Louis DN, Schramm J, Wiestler OD, von Deimling A: Molecular genetic subtypes of oligoastrocytomas. J Neuropathol Exp Neurol 1997;56:1098-1104.
11. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998;90:1473-1479.
12. Parney IF, Hao C, Petruk KC: Glioma immunology and immunotherapy. Neurosurgery 2000;46:778-792.
13. Ben-Yosef R, Bravermann I, Saah D, Nagler R, Shohat S, Or R, Nagler A: Mucosal melanoma following autologous stem cell transplantation for non-Hodgkin's lymphoma (NHL). Bone Marrow Transplant 1996;18:1017-1019.
14. Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G, Varadi G, Kirschbaum M, Ackerstein A, Samuel S, Amar A, Brautbar C, Ben-Tal O, Eldor A, Or R: Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematological diseases. Blood 1998;91:756-763.
15. Nagler A, Aker M, Or R, Naparstek E, Varadi G, Brautbar C, Slavin S: Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation. Exp Hematol 2001;29:1-9.